Figure 1.
Study flow diagram. ∗ indicates patients were deemed ineligible if their diagnosis was not listed on inclusion criteria, they were not within the allowed age range, the patient was not offered an AML-like therapy with curative intent, and/or the patient was not able to speak/read English; †, patient was too tired (n = 18), overwhelmed with diagnosis (n = 33), too occupied with treatment (n = 30), not interested in the study (n = 24), did not like the way the study was presented (n = 1), did not understand why the study was important (n = 1), and/or had a different reason (n = 24); ‡, patient transferred to receive initial treatment at another institution (n = 1), patient not within allowed age range (n = 1), did not have eligible diagnosis or disease status at enrollment (n = 10), received palliative care as main treatment or did not receive treatment (n = 6), and/or consented >7 days after day 1 of treatment (n = 11); §, received HCT as initial treatment (n = 10); and ¶, unable to reach patient (n = 59), withdrawn per patient request (n = 28), and/or data included for time points available.